Jonsson Comprehensive Cancer Center
🇺🇸United States
Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-07-31
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 19
- Registration Number
- NCT00509431
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma
- First Posted Date
- 2007-05-10
- Last Posted Date
- 2020-10-26
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 32
- Registration Number
- NCT00471887
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer
- First Posted Date
- 2007-04-13
- Last Posted Date
- 2012-10-04
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00460200
Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy
Completed
- Conditions
- First Posted Date
- 2007-03-22
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 36
- Registration Number
- NCT00450567
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy Participants
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-03-07
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 3
- Registration Number
- NCT00444223
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-02-12
- Last Posted Date
- 2012-10-04
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT00433407
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer
Phase 2
Terminated
- Conditions
- First Posted Date
- 2007-01-29
- Last Posted Date
- 2016-08-01
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 75
- Registration Number
- NCT00427427
- Locations
- 🇺🇸
Revlon/UCLA Breast Center, Los Angeles, California, United States
Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
Completed
- Conditions
- First Posted Date
- 2006-07-13
- Last Posted Date
- 2016-07-07
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 174
- Registration Number
- NCT00351728
- Locations
- 🇺🇸
Jules Stein Eye Institute, Los Angeles, California, United States
Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
- First Posted Date
- 2006-06-29
- Last Posted Date
- 2013-01-08
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 19
- Registration Number
- NCT00345826
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
Terminated
- Conditions
- First Posted Date
- 2006-06-29
- Last Posted Date
- 2019-08-12
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT00346372
- Locations
- 🇺🇸
Jules Stein Eye Institute, Los Angeles, California, United States
© Copyright 2024. All Rights Reserved by MedPath